Related Experiment Video
Updated: Mar 17, 2026
06:16
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
Published on: April 19, 2024
2.0K
Bleeding related to disturbed fibrinolysis
Krasimir Kolev1, Colin Longstaff2
1Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary.
British Journal of Haematology
|August 2, 2016
Summary
The fibrinolysis system, crucial for blood clot breakdown, faces modeling challenges due to its interface with fibrin. Antifibrinolytic drugs treat dangerous hyperfibrinolysis, a condition requiring better diagnostic tools.
Area of Science:
- Biochemistry
- Hematology
- Physiology
Background:
- The fibrinolysis system, responsible for blood clot dissolution, is less complex than coagulation but presents unique modeling challenges.
- Generating quantitative models of fibrinolysis is complicated by its operation at the solid-liquid interface of fibrin.
- Diagnostic tools for fibrinolysis malfunctions are less developed compared to coagulation disorders.
Purpose of the Study:
- To review the components and reactions of the fibrinolysis system.
- To discuss the challenges in quantitative modeling of fibrinolysis.
- To cover inherited and acquired pathologies involving hyperfibrinolysis and available treatments.
Main Methods:
- Review of existing literature on the fibrinolysis system.
- Analysis of the complexities in fibrinolysis pathway modeling.
- Discussion of diagnostic approaches and therapeutic strategies for hyperfibrinolysis.
Main Results:
- The fibrinolysis system's components and reactions are well-understood.
- Quantitative modeling is hindered by the solid-liquid interface of fibrin.
- Hyperfibrinolysis presents serious health risks, necessitating effective antifibrinolytic therapies.
Conclusions:
- Despite understanding its components, fibrinolysis modeling remains complex.
- Improved diagnostic tools for fibrinolysis are needed.
- Antifibrinolytic drugs are vital for managing hyperfibrinolysis and related pathologies.
Related Concept Videos
01:16Clot Retraction and Fibrinolysis
9.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.9K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
14.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.7K
01:24Disorders of Hemostasis
2.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
01:29Venous Thrombosis III: Interprofessional Care
453
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
453
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
01:22Formation of the Platelet Plug
10.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.4K